Insider Transactions in Q2 2021 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2021
|
William Grossman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,891
-15.81%
|
$89,493
$23.68 P/Share
|
|
Jun 17
2021
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Direct |
2,675
-1.33%
|
$61,525
$23.68 P/Share
|
|
Jun 17
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,863
-3.47%
|
$111,849
$23.68 P/Share
|
|
Jun 17
2021
|
Terry J Rosen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,863
-2.31%
|
$111,849
$23.68 P/Share
|
|
Jun 17
2021
|
Carolyn C. Tang General Counsel |
SELL
Open market or private sale
|
Direct |
1,606
-9.46%
|
$36,938
$23.68 P/Share
|
|
Jun 16
2021
|
William Grossman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,174
-5.74%
|
$76,176
$24.45 P/Share
|
|
Jun 16
2021
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Direct |
2,182
-0.54%
|
$52,368
$24.45 P/Share
|
|
Jun 16
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,968
-1.38%
|
$95,232
$24.45 P/Share
|
|
Jun 16
2021
|
Terry J Rosen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,968
-0.93%
|
$95,232
$24.45 P/Share
|
|
Jun 16
2021
|
Carolyn C. Tang General Counsel |
SELL
Open market or private sale
|
Direct |
1,309
-3.59%
|
$31,416
$24.45 P/Share
|
|
Jun 04
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,044
-0.87%
|
$25,056
$24.91 P/Share
|
|
Jun 03
2021
|
Kathryn E Falberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+3.35%
|
-
|
|
Jun 03
2021
|
Yasunori Kaneko Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+33.33%
|
-
|
|
Jun 03
2021
|
David L. Lacey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+7.25%
|
-
|
|
Jun 03
2021
|
Patrick Machado Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+33.33%
|
-
|
|
Jun 03
2021
|
Andrew J Perlman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+35.19%
|
-
|
|
Jun 03
2021
|
Antoni Ribas Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+21.35%
|
-
|
|
Apr 23
2021
|
William Grossman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,133
-38.09%
|
$128,123
$31.37 P/Share
|
|
Apr 23
2021
|
Yasunori Kaneko Director |
BUY
Open market or private purchase
|
Direct |
4,133
+36.69%
|
$128,123
$31.37 P/Share
|